Sheetal Kumar

Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 Individuals.

R. Grimalt, C. Fischer, O. Birk, 2022, JAMA dermatology.

Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture.

Yudong D. He, L. D. Ward, M. Guillot, 2020, Regulatory toxicology and pharmacology : RTP.

Next-generation phenotyping integrated in a national framework for patients with ultra-rare disorders improves genetic diagnostics and yields new molecular findings

Heinen, Heiko, Kehrer, 2023, medRxiv.